16:09 EST Cadrenal Therapeutics (CVKD) files to sell 590K shares of common stock for holders
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVKD:
- Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
- Cadrenal Therapeutics Advances Tecarfarin Development
- Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
- Cadrenal Therapeutics raises $5.1M via at-the-market facility
- Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
